Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Indivior (INDV)

Price 1,473.00p on 26-05-2023 at 16:52:12
Change -16.00p -1.07%
Buy 1,476.00p
Sell 1,472.00p
Buy / Sell INDV Shares
Last Trade: Unknown 569.00 at 1,473.178p
Day's Volume: 257,999
Last Close: 1,473.00p
Open: 1,471.00p
Day's Range 1,455.00p - 1,490.00p
52wk Range: 1,330.00p - 2,020.00p
Market Capitalisation: £2,031m
VWAP: 1,471.49996p
Shares in Issue: 138m

Recent Trades History Indivior (INDV)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 569 1,473.178p Ordinary
Currency Conversion
OTC Trade
16:52:12 - 26-May-23
Unknown* 58 1,473.00p Ordinary
Currency Conversion
OTC Trade
16:51:16 - 26-May-23
Unknown* 3,030 1,473.686p Ordinary
Currency Conversion
OTC Trade
16:48:35 - 26-May-23
Unknown* 314 1,473.00p Ordinary
Currency Conversion
16:34:37 - 26-May-23
Unknown* 263 1,473.00p Ordinary
Currency Conversion
OTC Trade
16:23:48 - 26-May-23
Unknown* 81 1,473.00p Ordinary
Currency Conversion
OTC Trade
16:23:07 - 26-May-23
Unknown* 214 1,470.59p Ordinary
OTC Trade
15:47:56 - 26-May-23
Unknown* 74,000 1,471.00p Ordinary
OTC Trade
15:42:58 - 26-May-23
Sell* 1,197 1,462.71125p Negotiated Trade
15:41:16 - 26-May-23
Unknown* 74,000 1,471.00p Ordinary
OTC Trade
15:36:07 - 26-May-23

Share Price History for Indivior

Time period:
Date Open High Low Close Volume

Share News for Indivior

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

25th May 2023 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

Indivior emergency opioid overdose treatment approved by US FDA

23rd May 2023 09:56

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose. Read More

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

10th May 2023 17:02

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2023 15:49

Read More

Indivior raises 2023 revenue forecast following Opiant acquisition

27th Apr 2023 13:46

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered